AoE Flu Seminars 2013
Date | Topic | Speaker |
16 Dec 2013 | The Weight of Acid Stability on the Pathogenesis of Influenza Virus | Dr Hassan Zaraket Department of Infectious Disease St Jude Children’s Research Hospital |
27 Nov 2013 | A role for gamma delta T cells in B cell development | Prof. Willi K. Born Integrated Department of Immunology National Jewish Health and University of Colorado Denver, Colorado, USA |
Protective role of gamma delta T cells in the prevention of autoimmunity of the eye | Prof. Rebecca L. O'Brien Integrated Department of Immunology National Jewish Health and University of Colorado Denver, Colorado, USA | |
Cellular stress sensing by gamma delta T cells: from immunobiology to immunotherapy | Prof. Marc Bonneville Research Director CNRS Cancer Research Center Inserm Unit 892, Nantes –Angers, France | |
Regulation of the antiviral host response by TRIM proteins | Prof. Adolfo Garcia-Sastre
Fishberg Professor Depts of Medicine & Microbiology Division of Infectious Diseases Director Global Health and Emerging Pathogens Institute Icahn School of Medicine at Mount Sinai, NY, USA | |
20 Nov 2013 | New therapies for antibiotic resistant infections | Prof Robert Hancock Centre for Microbial Diseases and Immunity Research Vancouver, Canada |
7 Nov 2013 | Studies to Estimate Influenza Vaccine Effectiveness | Dr Sheena Sullivan Medical Scientist Victorian Infectious Disease Research Laboratory Melbourne, Australia |
Protection against influenza by Human monoclonal antibodies: virus neutralization versus ADCC | Prof Jaap Goudsmit Crucell Vaccine Institute Janssen Center of Excellence for Immunoprophylaxis | |
15 Oct 2013 | Definition of a broadly neutralizing antibody target on the glycan shield of HIV-1 envelope glycoprotein gp120: an opportunity for vaccine design | Dr Leopold L Kong Post-doctorate Researcher Department of Integrative Structural and Computational Biology The Scripps Research Institute California USA |
7 Oct 2013 | One Health: A Promising Approach to Difficult Public Health Problems | Professor Gregory C. Gray Department of Environmental and Global Health College of Public Health and Health Professions University of Florida |
13 Aug 2013 | Repurposing of Approved Drugs for Acute Respiratory and Enterovirus Infections | Prof. Dr. Ralf M. Altmeyer Director General Institut Pasteur of Shanghai Chinese Academy of Sciences |
23 July 2013 | Influenza: To be or Not to be (Mutation Prone), that is the (Darwinian) Question | Dr Peter Cheung School of Public Health HKU |
Age and Gender Differences of Influenza-Associated Hospitalization in Hong Kong, 2004–2010 | Erin Wang School of Public Health HKU | |
17 Jul 2013 | What Determines Influenza Vaccine Effectiveness | Prof Arnold Monto School of Public Health University of Michigan USA |
15 May 2013 | Bridging Innate and Adaptive Immune Defense against Influenza A Virus Infection | Dr Iris Pang School of Public Health The University of Hong Kong |
Study of Nuclear Factor 90 against Influenza A Virus Replication | Ms Xi Wen Department of Microbiology The University of Hong Kong | |
9 May 2013 | Neuraminidase Dependent Multi-organ Replication of an H7 Influenza Virus | Dr Young-Ki Choi Department of Microbiology College of Medicine Chungbuk National University South Korea |
27 Mar 2013 | The Big Bang of Swine Influenza Viruses after 2009 | Dr Maria Zhu School of Public Health The University of Hong Kong |
Patterns in Influenza Viral Shedding and Factors Affecting Influenza Transmission within Households | Dr Lincoln Lau School of Public Health The University of Hong Kong | |
11 Mar 2013 | HIV-1 and influenza immunogen design | Prof Raghavan Varadarajan Molecular Biophysics Unit Indian Institute of Science |
1 Mar 2013 | Bridging the Gap between Data-Driven Knowledge Discovery and Medicine | Dr Gianni Panagiotou School of Biological Sciences HKU |
30 Jan 2013 | Modulation of RNA Granules by Non-Structural Protein 1 (NS1) of Influenza A Virus during Infection | Dr Bobo Mok Department of Microbiology The University of Hong Kong |
A Substantial Proportion of Pandemic Influenza A/H1N1 Infections were Seronegative at Titer Levels Typically used for Estimating Infection Attack Rates | Dr Joseph TK Wu School of Public Health The University of Hong Kong | |
28 Jan 2013 | Clinical Development of MVA-NP+M1, a T Cell Boosting Vaccine Against Influenza | Professor Sarah C Gilbert Professor of Vaccinology The Jenner Institute Oxford University, UK |
23 Jan 2013 | Monoglycosylated Hemagglutinin as a Better Influenza Vaccine | Dr Che Alex Ma Genomics Research Center Academia Sinica, Taiwan Professor William S James |